Detalhe da pesquisa
1.
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Future Oncol
; 18(12): 1449-1459, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040698
2.
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 20(5): 711-718, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922731
3.
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
Oncologist
; 22(3): 264-271, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209746
4.
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
; 23(7): 726-34, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24830357
5.
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
J Immunother Cancer
; 12(3)2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485190
6.
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
J Immunother Cancer
; 12(1)2024 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242717
7.
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Cancer
; 119(24): 4290-8, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122767
8.
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Cancer
; 119(14): 2555-63, 2013 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23605883
9.
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.
J Clin Oncol
; 41(5): 974-979, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608305
10.
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.
EClinicalMedicine
; 58: 101917, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090438
11.
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.
Oncologist
; 17(12): 1486-95, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23015662
12.
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Cancer Cell
; 40(12): 1537-1549.e12, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400018
13.
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer.
J Clin Oncol
; 38(26): 2981-2992, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167863
14.
BRAFV600 mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study.
Onco Targets Ther
; 10: 965-971, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28255242
15.
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
J Clin Oncol
; 33(13): 1475-81, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512461
16.
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.
Clin Colorectal Cancer
; 10(3): 171-7, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21855038
17.
Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.
J Clin Oncol
; 27(11): 1850-6, 2009 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19255328
18.
A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma.
Invest New Drugs
; 26(4): 381-6, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18305899
19.
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.
Cancer
; 113(3): 559-65, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18521920
20.
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
J Clin Oncol
; 26(21): 3523-9, 2008 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18640933